American Association for Cancer Research
Browse
00085472can083000-sup-sfig_1.pdf (52.52 kB)

Supplementary Figure 1 from Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase

Download (52.52 kB)
journal contribution
posted on 2023-03-30, 19:14 authored by Hélène Maby-El Hajjami, Patricia Amé-Thomas, Céline Pangault, Olivier Tribut, John DeVos, Rachel Jean, Nadège Bescher, Céline Monvoisin, Joëlle Dulong, Thierry Lamy, Thierry Fest, Karin Tarte
Supplementary Figure 1 from Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase

History

ARTICLE ABSTRACT

Human mesenchymal stem cells (MSC) strongly repress activated T-cell proliferation through the production of a complex set of soluble factors, including the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), which is induced by IFN-γ. Conversely, MSCs support survival of follicular lymphoma (FL) B cells, in particular after exposure to tumor necrosis factor-α (TNF) and lymphotoxin-α1β2 (LT). The role of MSCs on normal and malignant B-cell growth in steady-state and inflammatory conditions remains to be fully explored. We show here that resting MSCs sustain activated normal B-cell proliferation and survival, whereas IFN-γ–conditioned MSCs mediate IDO–dependent B-cell growth arrest and apoptosis. IFN-γ, TNF, and LT are significantly overexpressed by the microenvironment of invaded FL-lymph nodes, but their relative expression patterns are highly heterogeneous between samples. In vitro, IFN-γ abrogates the B-cell supportive phenotype induced by TNF and LT on MSCs. Moreover, IFN-γ overrules the growth promoting effect of MSCs on primary purified FL B cells. Altogether, these results underline the crucial role of the cytokine context in the local crosstalk between malignant cells and their microenvironment and provide new insights into our knowledge of the FL cell niche that emerges as a new promising target for innovative therapeutic strategies. [Cancer Res 2009;69(7):3228–37]

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC